BIOLASE, Inc. (BIOL)
USD 0.02
(27.39%)
USD 0.02
(27.39%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 35.1 Million USD | -8.08% |
| 2022 | 38.18 Million USD | -30.93% |
| 2021 | 55.28 Million USD | 34.76% |
| 2020 | 41.02 Million USD | 28.82% |
| 2019 | 31.84 Million USD | -17.31% |
| 2018 | 38.51 Million USD | -10.39% |
| 2017 | 42.98 Million USD | 2.49% |
| 2016 | 41.94 Million USD | -0.73% |
| 2015 | 42.25 Million USD | -28.87% |
| 2014 | 59.4 Million USD | 91.39% |
| 2013 | 31.03 Million USD | -2.92% |
| 2012 | 31.97 Million USD | 7.27% |
| 2011 | 29.8 Million USD | 64.25% |
| 2010 | 18.14 Million USD | -18.17% |
| 2009 | 22.17 Million USD | -37.89% |
| 2008 | 35.7 Million USD | -19.41% |
| 2007 | 44.3 Million USD | -8.79% |
| 2006 | 48.57 Million USD | 7.64% |
| 2005 | 45.12 Million USD | -23.18% |
| 2004 | 58.74 Million USD | 32.01% |
| 2003 | 44.5 Million USD | 209.14% |
| 2002 | 14.39 Million USD | 90.38% |
| 2001 | 7.56 Million USD | 14.58% |
| 2000 | 6.59 Million USD | 146.94% |
| 1999 | 2.67 Million USD | -31.48% |
| 1998 | 3.9 Million USD | 14.71% |
| 1997 | 3.4 Million USD | -27.66% |
| 1996 | 4.7 Million USD | 88.0% |
| 1995 | 2.5 Million USD | 4.17% |
| 1994 | 2.4 Million USD | -52.94% |
| 1993 | 5.1 Million USD | -8.93% |
| 1992 | 5.6 Million USD | 0.0% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q1 | 34.35 Million USD | -2.13% |
| 2024 Q2 | 30.64 Million USD | -10.81% |
| 2023 Q1 | 41.94 Million USD | 9.84% |
| 2023 FY | 35.1 Million USD | -8.08% |
| 2023 Q3 | 38.74 Million USD | -2.24% |
| 2023 Q2 | 39.63 Million USD | -5.51% |
| 2023 Q4 | 35.1 Million USD | -9.41% |
| 2022 Q3 | 42.86 Million USD | -15.71% |
| 2022 Q4 | 38.18 Million USD | -10.92% |
| 2022 FY | 38.18 Million USD | -30.93% |
| 2022 Q1 | 50.24 Million USD | -9.12% |
| 2022 Q2 | 50.85 Million USD | 1.22% |
| 2021 Q1 | 63.48 Million USD | 54.74% |
| 2021 Q2 | 61.24 Million USD | -3.52% |
| 2021 FY | 55.28 Million USD | 34.76% |
| 2021 Q3 | 58.51 Million USD | -4.47% |
| 2021 Q4 | 55.28 Million USD | -5.52% |
| 2020 Q2 | 27.75 Million USD | 13.15% |
| 2020 FY | 41.02 Million USD | 28.82% |
| 2020 Q1 | 24.53 Million USD | -22.97% |
| 2020 Q3 | 41.99 Million USD | 51.3% |
| 2020 Q4 | 41.02 Million USD | -2.31% |
| 2019 Q1 | 33.81 Million USD | -12.22% |
| 2019 Q3 | 28.27 Million USD | -12.64% |
| 2019 Q4 | 31.84 Million USD | 12.64% |
| 2019 FY | 31.84 Million USD | -17.31% |
| 2019 Q2 | 32.36 Million USD | -4.28% |
| 2018 Q3 | 34.25 Million USD | -3.91% |
| 2018 Q1 | 40.38 Million USD | -6.05% |
| 2018 FY | 38.51 Million USD | -10.39% |
| 2018 Q4 | 38.51 Million USD | 12.44% |
| 2018 Q2 | 35.64 Million USD | -11.72% |
| 2017 Q4 | 42.98 Million USD | 15.08% |
| 2017 FY | 42.98 Million USD | 2.49% |
| 2017 Q1 | 37.04 Million USD | -11.69% |
| 2017 Q2 | 42.28 Million USD | 14.15% |
| 2017 Q3 | 37.35 Million USD | -11.66% |
| 2016 FY | 41.94 Million USD | -0.73% |
| 2016 Q4 | 41.94 Million USD | -6.0% |
| 2016 Q3 | 44.61 Million USD | 23.94% |
| 2016 Q1 | 38.41 Million USD | -9.07% |
| 2016 Q2 | 36 Million USD | -6.29% |
| 2015 Q2 | 51.34 Million USD | -6.13% |
| 2015 Q1 | 54.69 Million USD | -7.93% |
| 2015 Q3 | 47.14 Million USD | -8.17% |
| 2015 FY | 42.25 Million USD | -28.87% |
| 2015 Q4 | 42.25 Million USD | -10.39% |
| 2014 Q2 | 26.39 Million USD | -7.88% |
| 2014 Q4 | 59.4 Million USD | 98.66% |
| 2014 Q1 | 28.65 Million USD | -7.67% |
| 2014 FY | 59.4 Million USD | 91.39% |
| 2014 Q3 | 29.9 Million USD | 13.27% |
| 2013 Q3 | 32.85 Million USD | 1.22% |
| 2013 Q2 | 32.46 Million USD | 6.35% |
| 2013 Q1 | 30.52 Million USD | -4.53% |
| 2013 FY | 31.03 Million USD | -2.92% |
| 2013 Q4 | 31.03 Million USD | -5.54% |
| 2012 Q2 | 28.21 Million USD | 1.15% |
| 2012 Q4 | 31.97 Million USD | 11.16% |
| 2012 Q1 | 27.89 Million USD | -6.42% |
| 2012 Q3 | 28.76 Million USD | 1.95% |
| 2012 FY | 31.97 Million USD | 7.27% |
| 2011 FY | 29.8 Million USD | 64.25% |
| 2011 Q2 | 29.91 Million USD | 47.34% |
| 2011 Q1 | 20.3 Million USD | 11.89% |
| 2011 Q3 | 29.39 Million USD | -1.76% |
| 2011 Q4 | 29.8 Million USD | 1.42% |
| 2010 Q4 | 18.14 Million USD | -6.91% |
| 2010 FY | 18.14 Million USD | -18.17% |
| 2010 Q3 | 19.49 Million USD | -3.88% |
| 2010 Q2 | 20.27 Million USD | 3.44% |
| 2010 Q1 | 19.6 Million USD | -11.6% |
| 2009 Q1 | 21.88 Million USD | -38.7% |
| 2009 Q2 | 22.41 Million USD | 2.41% |
| 2009 Q3 | 23.25 Million USD | 3.74% |
| 2009 Q4 | 22.17 Million USD | -4.63% |
| 2009 FY | 22.17 Million USD | -37.89% |
| 2008 Q2 | 38.61 Million USD | -7.38% |
| 2008 Q1 | 41.69 Million USD | -5.9% |
| 2008 Q4 | 35.7 Million USD | -12.79% |
| 2008 Q3 | 40.94 Million USD | 6.03% |
| 2008 FY | 35.7 Million USD | -19.41% |
| 2007 Q2 | 42.76 Million USD | -4.55% |
| 2007 FY | 44.3 Million USD | -8.79% |
| 2007 Q1 | 44.8 Million USD | -7.77% |
| 2007 Q3 | 40.04 Million USD | -6.37% |
| 2007 Q4 | 44.3 Million USD | 10.65% |
| 2006 Q4 | 48.57 Million USD | 13.27% |
| 2006 Q2 | 42.74 Million USD | -2.9% |
| 2006 FY | 48.57 Million USD | 7.64% |
| 2006 Q3 | 42.88 Million USD | 0.33% |
| 2006 Q1 | 44.02 Million USD | -2.44% |
| 2005 Q1 | 53.82 Million USD | -8.38% |
| 2005 Q4 | 45.12 Million USD | 3.12% |
| 2005 FY | 45.12 Million USD | -23.18% |
| 2005 Q3 | 43.76 Million USD | -9.13% |
| 2005 Q2 | 48.16 Million USD | -10.52% |
| 2004 FY | 58.74 Million USD | 32.01% |
| 2004 Q1 | 82.37 Million USD | 85.11% |
| 2004 Q2 | 85.42 Million USD | 3.71% |
| 2004 Q3 | 72.54 Million USD | -15.07% |
| 2004 Q4 | 58.74 Million USD | -19.03% |
| 2003 FY | 44.5 Million USD | 209.14% |
| 2003 Q4 | 44.5 Million USD | 69.11% |
| 2003 Q3 | 26.31 Million USD | 2.77% |
| 2003 Q2 | 25.6 Million USD | 60.85% |
| 2003 Q1 | 15.91 Million USD | 10.59% |
| 2002 Q4 | 14.39 Million USD | 26.05% |
| 2002 Q3 | 11.42 Million USD | 14.42% |
| 2002 Q1 | 9.15 Million USD | 21.03% |
| 2002 FY | 14.39 Million USD | 90.38% |
| 2002 Q2 | 9.98 Million USD | 9.07% |
| 2001 Q2 | 5.73 Million USD | 10.13% |
| 2001 Q1 | 5.2 Million USD | -21.11% |
| 2001 Q4 | 7.56 Million USD | 21.25% |
| 2001 Q3 | 6.23 Million USD | 8.77% |
| 2001 FY | 7.56 Million USD | 14.58% |
| 2000 Q3 | 6.59 Million USD | 5.13% |
| 2000 Q1 | 6.16 Million USD | 130.86% |
| 2000 Q2 | 6.27 Million USD | 1.76% |
| 2000 Q4 | 6.59 Million USD | -0.0% |
| 2000 FY | 6.59 Million USD | 146.94% |
| 1999 Q3 | 3.9 Million USD | -18.75% |
| 1999 FY | 2.67 Million USD | -31.48% |
| 1999 Q4 | 2.67 Million USD | -31.48% |
| 1999 Q1 | 6.5 Million USD | 66.67% |
| 1999 Q2 | 4.8 Million USD | -26.15% |
| 1998 Q2 | 5.8 Million USD | 75.76% |
| 1998 Q1 | 3.3 Million USD | -2.94% |
| 1998 FY | 3.9 Million USD | 14.71% |
| 1998 Q3 | 4.6 Million USD | -20.69% |
| 1998 Q4 | 3.9 Million USD | -15.22% |
| 1997 Q1 | 4.8 Million USD | 2.13% |
| 1997 FY | 3.4 Million USD | -27.66% |
| 1997 Q2 | 4 Million USD | -16.67% |
| 1997 Q3 | 3.7 Million USD | -7.5% |
| 1997 Q4 | 3.4 Million USD | -8.11% |
| 1996 Q4 | 4.7 Million USD | 370.0% |
| 1996 Q3 | 1 Million USD | -33.33% |
| 1996 Q2 | 1.5 Million USD | -25.0% |
| 1996 FY | 4.7 Million USD | 88.0% |
| 1996 Q1 | 2 Million USD | -20.0% |
| 1995 Q2 | 2.1 Million USD | 23.53% |
| 1995 Q1 | 1.7 Million USD | -29.17% |
| 1995 Q3 | 3 Million USD | 42.86% |
| 1995 Q4 | 2.5 Million USD | -16.67% |
| 1995 FY | 2.5 Million USD | 4.17% |
| 1994 Q2 | 3 Million USD | 0.0% |
| 1994 Q4 | 2.4 Million USD | -41.46% |
| 1994 FY | 2.4 Million USD | -52.94% |
| 1994 Q3 | 4.1 Million USD | 36.67% |
| 1993 Q1 | 4.7 Million USD | -16.07% |
| 1993 Q2 | 4.4 Million USD | -6.38% |
| 1993 Q3 | 4.2 Million USD | -4.55% |
| 1993 FY | 5.1 Million USD | -8.93% |
| 1993 Q4 | 5.1 Million USD | 21.43% |
| 1992 Q4 | 5.6 Million USD | 0.0% |
| 1992 FY | 5.6 Million USD | 0.0% |
| 1992 Q2 | 5.3 Million USD | 0.0% |
| 1992 Q3 | 5.6 Million USD | 5.66% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 31.36 Million USD | -11.908% |
| Sight Sciences, Inc. | 166.65 Million USD | 78.937% |
| TELA Bio, Inc. | 78.04 Million USD | 55.026% |
| Acutus Medical, Inc. | 53.96 Million USD | 34.95% |
| Talis Biomedical Corporation | 98.34 Million USD | 64.306% |
| PetVivo Holdings, Inc. | 3.11 Million USD | -1026.746% |
| Bioventus Inc. | 810.91 Million USD | 95.671% |
| BrainsWay Ltd. | 62.97 Million USD | 44.259% |
| Envoy Medical, Inc. | 7.64 Million USD | -359.437% |
| CVRx, Inc. | 115.22 Million USD | 69.538% |
| electroCore, Inc. | 16.38 Million USD | -114.2% |
| NeuroOne Medical Technologies Corporation | 8.09 Million USD | -333.489% |
| Orthofix Medical Inc. | 925.31 Million USD | 96.207% |
| DIH Holding US, Inc. Warrants | 58.66 Million USD | 40.163% |
| Helius Medical Technologies, Inc. | 7.69 Million USD | -356.331% |
| IceCure Medical Ltd | 16.41 Million USD | -113.9% |
| Inogen, Inc. | 326.19 Million USD | 89.239% |
| OrthoPediatrics Corp. | 449.58 Million USD | 92.193% |
| Lucid Diagnostics Inc. | 27.27 Million USD | -28.717% |
| Spectral AI, Inc. | 10.69 Million USD | -228.292% |
| Monogram Orthopaedics, Inc. | 16.57 Million USD | -111.72% |
| MaxCyte, Inc. | 268.27 Million USD | 86.916% |
| NanoVibronix, Inc. | 6.67 Million USD | -425.936% |
| Nano-X Imaging Ltd. | 218.64 Million USD | 83.946% |
| Nexalin Technology, Inc. | 3.63 Million USD | -866.46% |
| PAVmed Inc | 33.11 Million USD | -5.984% |
| QT Imaging Holdings, Inc. | 23.39 Million USD | -50.013% |
| Rapid Micro Biosystems, Inc. | 143.45 Million USD | 75.531% |
| RxSight, Inc. | 182.55 Million USD | 80.772% |
| SI-BONE, Inc. | 230.42 Million USD | 84.767% |
| Treace Medical Concepts, Inc. | 251.9 Million USD | 86.066% |
| Vivos Therapeutics, Inc. | 10.73 Million USD | -227.13% |
| Cerus Corporation | 197.74 Million USD | 82.25% |
| Venus Concept Inc. | 93.65 Million USD | 62.521% |
| TriSalus Life Sciences, Inc. | 25.72 Million USD | -36.447% |
| LivaNova PLC | 2.42 Billion USD | 98.555% |
| 908 Devices Inc. | 202.98 Million USD | 82.707% |
| Alphatec Holdings, Inc. | 805.2 Million USD | 95.641% |
| Nemaura Medical Inc. | 14.56 Million USD | -141.025% |
| NeuroPace, Inc. | 107.65 Million USD | 67.394% |
| LENSAR, Inc. | 69.58 Million USD | 49.557% |
| Apyx Medical Corporation | 79.24 Million USD | 55.703% |
| Cutera, Inc. | 346.29 Million USD | 89.864% |
| STRATA Skin Sciences, Inc. | 42.01 Million USD | 16.458% |
| BioSig Technologies, Inc. | 1.79 Million USD | -1852.225% |
| Anika Therapeutics, Inc. | 270.63 Million USD | 87.03% |
| ClearPoint Neuro, Inc. | 42.66 Million USD | 17.721% |
| Integra LifeSciences Holdings Corporation | 3.78 Billion USD | 99.072% |
| Axonics, Inc. | 719.92 Million USD | 95.124% |
| Outset Medical, Inc. | 313.8 Million USD | 88.814% |
| IRIDEX Corporation | 34.43 Million USD | -1.931% |
| PROCEPT BioRobotics Corporation | 404.71 Million USD | 91.327% |
| IRadimed Corporation | 92.15 Million USD | 61.911% |
| Tivic Health Systems, Inc. | 5.25 Million USD | -568.081% |
| INVO Bioscience, Inc. | 20.88 Million USD | -68.046% |
| Telesis Bio, Inc. | 70.41 Million USD | 50.148% |
| Viemed Healthcare, Inc. | 154.1 Million USD | 77.222% |
| Varex Imaging Corporation | 1.24 Billion USD | 97.191% |
| Quipt Home Medical Corp. | 247.4 Million USD | 85.813% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -277.025% |
| Pulmonx Corporation | 178.95 Million USD | 80.385% |
| Dynatronics Corporation | 25.94 Million USD | -35.313% |
| Modular Medical, Inc. | 13.8 Million USD | -154.226% |
| ReShape Lifesciences Inc. | 10.72 Million USD | -227.221% |
| Semler Scientific, Inc. | 78.06 Million USD | 55.036% |
| InMode Ltd. | 863.28 Million USD | 95.934% |
| Bruker Corporation | 4.24 Billion USD | 99.174% |
| Cytosorbents Corporation | 53.26 Million USD | 34.096% |
| DexCom, Inc. | 6.26 Billion USD | 99.44% |
| Align Technology, Inc. | 6.08 Billion USD | 99.423% |
| Viveve Medical, Inc. | 25.91 Million USD | -35.457% |
| ZimVie Inc. | 1.2 Billion USD | 97.088% |
| Movano Inc. | 9.42 Million USD | -272.583% |
| Cytek Biosciences, Inc. | 497.66 Million USD | 92.947% |
| Nexalin Technology, Inc. | 3.63 Million USD | -866.46% |
| DIH Holdings US, Inc. Class A Common Stock | 58.66 Million USD | 40.163% |
| Tandem Diabetes Care, Inc. | 952.65 Million USD | 96.315% |
| Profound Medical Corp. | 43.68 Million USD | 19.652% |
| Insulet Corporation | 2.58 Billion USD | 98.644% |
| enVVeno Medical Corporation | 48.63 Million USD | 27.828% |
| Surmodics, Inc. | 185.73 Million USD | 81.101% |
| iCAD, Inc. | 41.41 Million USD | 15.252% |
| Nuwellis, Inc. | 9.77 Million USD | -259.273% |
| Biotricity, Inc. | 5.94 Million USD | -490.665% |
| iRhythm Technologies, Inc. | 433.14 Million USD | 91.896% |
| Aethlon Medical, Inc. | 8.24 Million USD | -325.674% |
| InspireMD, Inc. | 47.64 Million USD | 26.325% |
| PAVmed Inc. | 33.11 Million USD | -5.984% |
| Beyond Air, Inc. | 56.96 Million USD | 38.377% |
| FONAR Corporation | 214.24 Million USD | 83.616% |
| AxoGen, Inc. | 196.82 Million USD | 82.167% |
| Vivani Medical, Inc. | 45.79 Million USD | 23.355% |
| Tactile Systems Technology, Inc. | 281.43 Million USD | 87.528% |
| Inari Medical, Inc. | 674.23 Million USD | 94.794% |
| UFP Technologies, Inc. | 404.13 Million USD | 91.315% |
| Heart Test Laboratories, Inc. | 9.5 Million USD | -269.363% |
| Tenon Medical, Inc. | 6.34 Million USD | -453.207% |
| Autonomix Medical, Inc. Common Stock | 9.4 Million USD | -273.137% |
| Co-Diagnostics, Inc. | 103.64 Million USD | 66.134% |
| AdaptHealth Corp. | 4.61 Billion USD | 99.24% |
| Sintx Technologies, Inc. | 15.36 Million USD | -128.448% |
| Quanterix Corporation | 425.01 Million USD | 91.741% |
| Inspira Technologies Oxy B.H.N. Ltd. | 9.31 Million USD | -277.025% |
| Sensus Healthcare, Inc. | 53.72 Million USD | 34.668% |
| Pacific Biosciences of California, Inc. | 1.74 Billion USD | 97.99% |
| TransMedics Group, Inc. | 706.04 Million USD | 95.029% |
| ReWalk Robotics Ltd. | 63.19 Million USD | 44.453% |
| NeuroMetrix, Inc. | 21.42 Million USD | -63.836% |
| Hyperfine, Inc. | 94.19 Million USD | 62.737% |
| Establishment Labs Holdings Inc. | 268.64 Million USD | 86.934% |
| Biomerica, Inc. | 9.25 Million USD | -279.306% |
| Bone Biologics Corporation | 3.73 Million USD | -839.091% |
| AVITA Medical, Inc. | 144.33 Million USD | 75.682% |
| Bluejay Diagnostics, Inc. | 4.86 Million USD | -620.977% |
| Silk Road Medical, Inc | 265.3 Million USD | 86.77% |